Clinical Trial Update: Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients [NA]

View source ↗

Summary

This completed prospective, double-blind randomized trial evaluated high-dose rabeprazole (Pariet) for the treatment of reflux laryngitis in Chinese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Laryngitis

Drugs mentioned

• Pariet (rabeprazole)

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Gastroesophageal Reflux, Laryngitis | NA | Status: COMPLETED